(Q36991587)

17 August 2017

Long-term treatment of Parkinson's disease with bromocriptine (English)

1 reference

17 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1136/JNNP.42.2.143

29 April 2023

author name string

A. Rascol

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

30 June 2022

B. Guiraud

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

30 June 2022

J. L. Montastruc

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

30 June 2022

J. David

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

30 June 2022

M. Clanet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

30 June 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

PMCID

490179

full work available at URL

17 August 2017

https://europepmc.org/articles/PMC490179

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

https://europepmc.org/articles/PMC490179?pdf=render

30 June 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A422961

https://syndication.highwire.org/content/doi/10.1136/jnnp.42.2.143

30 June 2022

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.42.2.143

Journal of Neurology, Neurosurgery and Psychiatry

29 April 2023

published in

1 reference

17 August 2017

42

1 reference

17 August 2017

2

1 reference

17 August 2017

143-150

1 reference

Treatment of parkinson's disease with bromocriptine

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Abnormal movements caused by L-DOPA in patients with Parkinson's disease: correlation with the plasma concentrations of DOPA and O-methyl-DOPA

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine treatment in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine in the treatment of advanced Parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Treatment of parkinsonian syndromes by bromocriptin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Success and problems of long-term levodopa therapy in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine and levodopa (with or without carbidopa) in parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Letter: Bromocriptine in parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine in Parkinsonism.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Treatment of parkinsonism with bromocriptine.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

CB 154 in the treatment of parkinson's disease--results of the association with L-DOPA + DDI (author's transl)

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

Bromocriptine and Parkinson's disease: initial results

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=490179

27 June 2018

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacological study of a possible dopamine metabolite, tetrahydropapaveroline

1 reference

PubMed

12 December 2020

Transient responses of the normal and diseased motor system to sudden load changes

1 reference

PubMed

12 December 2020

Parkinsonism: onset, progression, and mortality

10

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.42.2.143

Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover

29 April 2023

22

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.42.2.143

29 April 2023

Identifiers

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

PMCID

490179